Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
1.19
0.01 (0.85%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.84%
After-hours: Aug 15, 2025, 04:10 PM EDT

Opus Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-57.53M -9.99M 17.89M -56.69M
Depreciation & Amortization
10K 6K 4K 4K
Stock-Based Compensation
3.36M 3.51M 1.81M 1.91M
Other Working Capital
6.31M 477K -190K -200K
Other Non-Cash Items
25.49M 1.28M 170K 35.22M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.09M 4.08M -5.55M 181K
Operating Cash Flow
-25.58M -1.11M 14.31M -19.37M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
1.21M n/a n/a -100K
Investing Cash Flow
1.21M n/a n/a -100K
Debt Repayment
n/a n/a -538K 538K
Common Stock Repurchased
-79K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-232K -248K -104K -1.42M
Financial Cash Flow
4.19M 8.98M 3.79M 27.61M
Net Cash Flow
-20.18M 7.87M 18.1M 8.13M
Free Cash Flow
-25.58M -1.11M 14.31M -19.37M